Drug profile · INN
ioxaglate meglumine
HEXABRIX
ioxaglate meglumine (HEXABRIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Drug details — ioxaglate meglumine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ioxaglate meglumine (HEXABRIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is ioxaglate meglumine?
ioxaglate meglumine (HEXABRIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ioxaglate meglumine?
HEXABRIX is a marketed brand name for ioxaglate meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ioxaglate meglumine?
ioxaglate meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.